Opportunity Information: Apply for PAR 19 179

The Shared Instrumentation Grant (SIG) Program (PAR 19-179) is a National Institutes of Health (NIH) discretionary grant opportunity designed to help research groups obtain major, high-cost scientific equipment that can be shared by multiple NIH-supported investigators. The core purpose is straightforward: strengthen biomedical and behavioral research capacity by enabling institutions to purchase or upgrade a single, expensive, specialized, commercially available instrument or an integrated instrumentation system that would be difficult to acquire through typical single-lab budgets. This opportunity is labeled "S10 Clinical Trial Not Allowed," meaning the grant mechanism is intended for instrumentation support rather than running clinical trials under this award.

Funding under this program supports one major equipment purchase or upgrade per application, emphasizing shared access and broad scientific impact across several active research projects. The minimum award amount is $50,000, and while there is no stated maximum allowable instrument price, the maximum NIH award is capped at $600,000. In practice, that means an instrument can cost more than $600,000, but the portion covered by the SIG award cannot exceed $600,000, so applicants typically need to plan carefully around any additional costs, institutional contributions, service contracts, facility renovations, or other non-award funding needs if applicable.

The program is geared toward sophisticated research instruments commonly used across many biomedical disciplines. Examples specifically noted include X-ray diffractometers, mass spectrometers, nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imaging systems. The list is not exhaustive, which signals that NIH is open to other types of specialized, commercially available instruments, as long as the request is well-justified, fits the intent of the program, and clearly benefits a group of NIH-funded investigators through a shared-use model.

Eligibility is broad across U.S.-based research and higher education organizations, including public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (both with and without 501(c)(3) status) that meet NIH requirements. The announcement also highlights eligibility for several institution types that serve specific communities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). At the same time, there are clear restrictions related to foreign participation: non-U.S. entities (foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible to apply, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. Because NIH definitions and edge cases can matter, applicants are expected to rely on the full funding announcement for the precise eligibility rules and compliance requirements.

Administratively, the agency is NIH, and the opportunity falls under the Health funding activity category, with CFDA numbers 93.351 and 93.859 listed. The source record shows an original closing date of May 31, 2019 and a creation date of January 30, 2019, which suggests this specific posting reflects a particular cycle or version of the program announcement. Anyone interested in applying would need to verify the current status of PAR 19-179, check for any reissues or updated announcements, and follow the latest NIH submission dates and policies referenced in the active funding opportunity.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351, 93.859.
  • This funding opportunity was created on 2019-01-30.
  • Applicants must submit their applications by 2019-05-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others.
Apply for PAR 19 179

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Shared Instrumentation Grant (SIG) Program (PAR 19-179) - FAQs

What is the Shared Instrumentation Grant (SIG) Program (PAR 19-179)?

The Shared Instrumentation Grant (SIG) Program (PAR 19-179) is a discretionary National Institutes of Health (NIH) grant opportunity that helps research groups obtain a major, high-cost scientific instrument that will be shared by multiple NIH-supported investigators. The goal is to strengthen biomedical and behavioral research capacity by enabling the purchase or upgrade of a single specialized, commercially available instrument or integrated instrumentation system.

What is the main purpose of this grant?

The core purpose is to support shared access to one expensive, specialized instrument (or an integrated system) that would be difficult to acquire through typical single-lab budgets, and that will broadly benefit multiple active, NIH-supported research projects.

What does "S10 Clinical Trial Not Allowed" mean for this opportunity?

"S10 Clinical Trial Not Allowed" indicates the award mechanism is intended for instrumentation support rather than running clinical trials under this award. The focus is on purchasing or upgrading equipment, not conducting clinical trial activities as part of the grant.

What does the SIG Program fund?

Funding supports one major equipment purchase or one major equipment upgrade per application. The program emphasizes shared use and broad scientific impact across several NIH-supported investigators and projects.

How many instruments can be requested in a single application?

Based on the program description provided, each application supports one major equipment purchase or upgrade. In other words, the request is centered on a single instrument or an integrated instrumentation system.

What is the minimum award amount?

The minimum award amount is $50,000.

What is the maximum award amount?

The maximum NIH award is capped at $600,000.

Is there a maximum allowable instrument price?

No maximum allowable instrument price is stated. However, even if the instrument costs more than $600,000, the portion covered by the NIH SIG award cannot exceed $600,000. Applicants typically need to plan for any remaining costs using non-award sources.

If the instrument costs more than $600,000, can applicants still apply?

Yes. The instrument can cost more than $600,000, but the NIH SIG award portion cannot exceed $600,000. That means applicants should plan for any additional costs beyond the award cap.

What types of additional costs might not be covered by the SIG award?

The description notes that applicants may need to plan around additional costs such as institutional contributions, service contracts, facility renovations, or other non-award funding needs, if applicable.

What kinds of instruments are considered appropriate for SIG funding?

The program is geared toward sophisticated, high-cost research instruments commonly used across many biomedical disciplines. Examples explicitly listed include:

  • X-ray diffractometers
  • Mass spectrometers
  • Nuclear magnetic resonance (NMR) spectrometers
  • DNA and protein sequencers
  • Biosensors
  • Electron and light microscopes
  • Cell sorters
  • Biomedical imaging systems

Is the list of eligible instruments limited to the examples provided?

No. The list is described as not exhaustive. NIH may consider other specialized, commercially available instruments, as long as the request is well-justified, fits the program intent, and clearly benefits multiple NIH-funded investigators through a shared-use model.

Does the requested equipment need to be commercially available?

Yes. The opportunity describes support for a specialized, commercially available instrument or an integrated instrumentation system.

What is meant by a "shared-use model" in this program?

The shared-use model means the instrument is intended to be accessible to multiple NIH-supported investigators, supporting several active research projects rather than being dedicated to a single lab or a single investigator.

Who is this program designed to benefit?

The program is designed to benefit groups of NIH-supported investigators by providing shared access to a major instrument that strengthens overall institutional research capacity in biomedical and behavioral research.

What organizations are eligible to apply?

Eligibility is broad for U.S.-based research and higher education organizations that meet NIH requirements, including:

  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • Nonprofit organizations (with or without 501(c)(3) status)

Are institutions that serve specific communities explicitly included as eligible?

Yes. The announcement highlights eligibility for several institution types, including:

  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)

Are foreign institutions eligible to apply?

No. Non-U.S. entities (foreign institutions) are not eligible to apply under the restrictions described.

Can non-U.S. components of U.S. organizations apply?

No. Non-U.S. components of U.S. organizations are not eligible to apply.

Are foreign components allowed under this opportunity?

No. Foreign components (as defined by the NIH Grants Policy Statement) are not allowed.

Why does NIH eligibility language matter for foreign participation?

The description notes that NIH definitions and edge cases can matter, so applicants are expected to rely on the full funding announcement for precise eligibility rules and compliance requirements.

Which federal agency administers this grant opportunity?

The administering agency is the National Institutes of Health (NIH).

What funding activity category does this opportunity fall under?

The opportunity falls under the Health funding activity category.

What CFDA numbers are associated with this opportunity?

CFDA numbers 93.351 and 93.859 are listed in the opportunity information provided.

What dates are shown for this opportunity posting?

The source record shows an original closing date of May 31, 2019 and a creation date of January 30, 2019, indicating the posting reflects a particular cycle or version of the program announcement.

Is PAR 19-179 still open or active?

The information provided suggests the posting corresponds to a specific 2019 cycle, so anyone interested would need to verify the current status of PAR 19-179, check for reissues or updated announcements, and follow the latest NIH submission dates and policies referenced in the active funding opportunity.

What should applicants do if they want to apply now?

Applicants should confirm whether PAR 19-179 has been reissued or replaced, verify current NIH submission dates, and follow the latest policies and requirements contained in the active funding opportunity announcement.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed

Previous opportunity: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 19 179

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 19 179) also looked into and applied for these:

Funding Opportunity
Computational Models of Immunity (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 011

Funding Number: RFA AI 19 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
High Quality Human Reference Genomes (HQRG) (U01 Clinical Trial Not Allowed) Apply for RFA HG 19 002

Funding Number: RFA HG 19 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed) Apply for RFA HG 19 004

Funding Number: RFA HG 19 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed) Apply for RFA HG 19 003

Funding Number: RFA HG 19 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) Apply for PAR 19 175

Funding Number: PAR 19 175
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 19 177

Funding Number: PAR 19 177
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) Apply for RFA HS 19 001

Funding Number: RFA HS 19 001
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 110

Funding Number: RFA MH 20 110
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) Apply for RFA AI 19 012

Funding Number: RFA AI 19 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed) Apply for PAR 19 185

Funding Number: PAR 19 185
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships Apply for 720611 LOCAL PARTNER STRATEGY MEETING

Funding Number: 720611 LOCAL PARTNER STRATEGY MEETING
Agency: Zambia USAID-Lusaka
Category: Health
Funding Amount: Case Dependent
Tuberculosis Implementation Framework Agreement (TIFA) Apply for 7200AA19RFA00008

Funding Number: 7200AA19RFA00008
Agency: Agency for International Development
Category: Health
Funding Amount: $300,000,000
Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 19 019

Funding Number: RFA OD 19 019
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) Apply for PAR 19 189

Funding Number: PAR 19 189
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 115

Funding Number: RFA MH 20 115
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional) Apply for PAR 19 204

Funding Number: PAR 19 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Not Allowed) Apply for PAR 19 203

Funding Number: PAR 19 203
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial Not Allowed) Apply for PAR 19 208

Funding Number: PAR 19 208
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) Apply for PAR 19 209

Funding Number: PAR 19 209
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 013

Funding Number: RFA AG 20 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 179", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: